Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

683 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
Vermeire S, van Assche G, Rutgeerts P. Vermeire S, et al. Aliment Pharmacol Ther. 2007 Jan 1;25(1):3-12. doi: 10.1111/j.1365-2036.2006.03134.x. Aliment Pharmacol Ther. 2007. PMID: 17229216 Review.
Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis.
Baert F, Vande Casteele N, Tops S, Noman M, Van Assche G, Rutgeerts P, Gils A, Vermeire S, Ferrante M. Baert F, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1324-32. doi: 10.1111/apt.12968. Epub 2014 Oct 2. Aliment Pharmacol Ther. 2014. PMID: 25277873
Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.
Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Mahadevan U, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2017 May;45(9):1284. doi: 10.1111/apt.14054. Aliment Pharmacol Ther. 2017. PMID: 28370036 No abstract available.
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
Vande Casteele N, Feagan BG, Vermeire S, Yassine M, Coarse J, Kosutic G, Sandborn WJ. Vande Casteele N, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2018 Jan;47(2):229-237. doi: 10.1111/apt.14421. Epub 2017 Nov 21. Aliment Pharmacol Ther. 2018. PMID: 29159893 Free PMC article.
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.
Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Mahadevan U, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2018 Aug;48(3):388-389. doi: 10.1111/apt.14855. Aliment Pharmacol Ther. 2018. PMID: 29998501 No abstract available.
Physicians' perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.
Olivera P, Sandborn WJ, Panés J, Baumann C, D'Haens G, Vermeire S, Danese S, Peyrin-Biroulet L. Olivera P, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2018 Mar;47(6):773-783. doi: 10.1111/apt.14514. Epub 2018 Jan 19. Aliment Pharmacol Ther. 2018. PMID: 29349829
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.
Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M. Mahadevan U, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. doi: 10.1111/apt.13960. Epub 2017 Feb 7. Aliment Pharmacol Ther. 2017. PMID: 28169436
Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.
Van Steenbergen S, Bian S, Vermeire S, Van Assche G, Gils A, Ferrante M. Van Steenbergen S, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2017 Apr;45(7):923-932. doi: 10.1111/apt.13964. Epub 2017 Feb 6. Aliment Pharmacol Ther. 2017. PMID: 28164321
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.
Billiet T, Cleynen I, Ballet V, Ferrante M, Van Assche G, Gils A, Vermeire S. Billiet T, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2016 Oct;44(7):673-83. doi: 10.1111/apt.13754. Epub 2016 Aug 9. Aliment Pharmacol Ther. 2016. PMID: 27502581
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease.
Feagan BG, Sandborn WJ, D'Haens G, Lee SD, Allez M, Fedorak RN, Seidler U, Vermeire S, Lawrance IC, Maroney AC, Jurgensen CH, Heath A, Chang DJ. Feagan BG, et al. Among authors: vermeire s. Aliment Pharmacol Ther. 2015 Nov;42(10):1170-81. doi: 10.1111/apt.13398. Epub 2015 Sep 23. Aliment Pharmacol Ther. 2015. PMID: 26400458 Clinical Trial.
683 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback